From 27 April to 30 April, the 23rd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) was held in Berlin, in which there were a number of sessions on viral hepatitis, which were very well attended.
On Saturday morning there was an Educational Workshop entitled Current challenges in the management of viral hepatitis. In this session 4 topics were presented starting with an overview of the treatment of hepatitis B treatment in resource limited settings (Resat Ozaras). Then 2 case-studies were presented ranging from treatment of HBsAg-positive patients under infliximab (Philippe Sogni) to hepatitis B during pregnancy (Hakan Leblebicioglu). The last presentation discussed new protease inhibitors in hepatitis C treatment (Joop Arends).
Together with the PK/PD of Anti-Infectives Study Group (EPASG), we organised on Tuesday an official symposium entitled The revolving alphabet soup of viral hepatitis. Again 4 topics regarding viral hepatitis were discussed starting with prevention and management of HBV in immunocompromised patients (Heiner Wedemeyer) followed by 2 talks on HCV therapy (Massimo Puoti and Ramazan Idilman). The last presentation was on hepatitis E in immunocompromised patients (Robert De Man).
All sessions have been recorded and webcasts plus the presentation slides are available in the ESCMID Online Lecture Library (www.escmid.org/OLL).
In all, at this ECCMID conference in Berlin there were many very interesting sessions on viral hepatitis with excellent speakers and many attendees. This is encouraging for coming ECCMID conferences.